Top Markets
Coin of the day
Zhejiang Jolly Pharmaceutical Co.,LTD Zhejiang Jolly Pharmaceutical Co.,LTD

Zhejiang Jolly Pharmaceutical Co.,LTD

300181
Xếp hạng trong cổ phiếu #8001
Zhejiang Jolly Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to... Zhejiang Jolly Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the research, manufacturing, and global distribution of traditional Chinese medicinal products. The company's diverse portfolio includes the Wuling capsule, prescribed for conditions such as insomnia, amnesia, heart palpitations, general fatigue, weakness in the lower back and legs, and tinnitus. This capsule also addresses energy deficiency and a weak pulse often linked to an imbalance of the heart and kidneys, or neurasthenia. Additionally, they produce the Lingze tablet, which targets frequent or painful urination, weak or continuous urine flow, and lower back and knee soreness, especially when these symptoms are associated with benign prostatic hyperplasia, kidney insufficiency, or blood stasis. Another offering, the Bailing tablet, serves as an adjunctive treatment for coughs, asthma, back pain, and chronic bronchitis stemming from lung and kidney deficiencies. The firm also markets Linglianhua particles, used to manage symptoms including excessive sweating, sleep disturbances, irritability, heart flutters, vivid dreams, dizziness with tinnitus, lower back and leg weakness, dry stools, an unusual tongue appearance, and a feeble pulse, often seen in perimenopausal syndrome or heart and kidney disharmony. Beyond these traditional Chinese medicine formulations, Zhejiang Jolly Pharmaceutical provides a range of injectable pharmaceuticals, such as azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside. The company further supplies raw medicinal ingredients, including cordyceps cephalosporium, fermented cordyceps, and Wuling powders. Expanding its reach into healthcare services, Zhejiang Jolly Pharmaceutical Co., Ltd. invests in and participates with Deqing No.3 People's Hospital. Established in 2000 and based in Huzhou, China, the entity now known as Zhejiang Jolly Pharmaceutical Co., Ltd. adopted this name in 1998, evolving from its earlier designation, Zhejiang Jolly Pharmaceutical Health Products Co., LTD.
Giá cổ phiếu
$2.00
Đồng bộ lần cuối: 2026-08-28
Vốn hóa thị trường
$1.39B
Thay đổi (1 ngày)
-2.67%
Thay đổi (1 năm)
-25.02%
Quốc gia
CN
Giao dịch Zhejiang Jolly Pharmaceutical Co.,LTD (300181)

Danh mục

EPS của Zhejiang Jolly Pharmaceutical Co.,LTD (300181)
EPS tính đến 2026 TTM: 0
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Zhejiang Jolly Pharmaceutical Co.,LTD, EPS hiện tại của công ty (TTM) là 0. Vào cuối năm 2026, công ty có EPS là 0, bằng với EPS năm 2026 là 0.
Lịch sử EPS của Zhejiang Jolly Pharmaceutical Co.,LTD từ 2026 đến 2026
EPS vào cuối mỗi năm
Năm EPS Thay đổi
Không đủ dữ liệu cho ngày được cung cấp.
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
Công ty EPS Chênh lệch EPS Quốc gia
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH